Kinase Logistics Products and Services

Kinase Logistics ApS has been appointed by Carna Biosciences, Inc., Japan as exclusive European agent.

Carna Biosciences, Inc., established in 2003, is a Japanese biotechnology company with focus on protein kinase products and services to support kinase drug development. For more information, please contact us.

Kinases

Currently available are 395 kinases.

Cytoplasmic tyrosine kinases

31 wild type forms

2 mutant forms

1 isoform

Receptor tyrosine kinases

48 wild type forms

28 mutant forms

Serine/threoine kinases

259 wild type forms

4 mutant forms

2 isoform

8 inactive forms

7 inactive mutant forms

Lipid kinases

3 wild type forms

Newly added kinases:

45 BIOTINYALTED KINASES

JAK2(JH1 JH2)

JAK2(JH1 JH2) [V617F]

HH498(TNNI3K)

Profiling and Screening

Profiling and screening service is available for 311 kinases.

Assays are done at km of ATP and for a subset of 166 kinases at 1 mM ATP. For details about assay conditions and reference inhibitor curves, please download the Kinase Profiling Book.

NEW

57 Tyrosine Kinase Cell-Based Panel

Kinase Assays

QuickScout^TM Screening Assist Kits for different assay platforms are available as ready-to-go products.

268 assays for MSA
78 assays for IMAP
22 assays for TR-FRET
110 assays for ELISA

For specific kinases and platforms assays can be developed and optimized. This assay development service includes

cloning
protein production
substrate search
assay development

Last Updated on Tuesday, 10 January 2012 07:01